With shares of Cisco (NASDAQ:CSCO) trading around $21, is CSCO an OUTPERFORM, WAIT AND SEE, or STAY AWAY? Let�� analyze the stock with the relevant sections of our CHEAT SHEET investing framework.
T = Trends for a Stock’s MovementCisco designs, manufactures, and sells Internet protocol-based networking and other products related to communications, and provides services associated with these products and their use to information technology industries worldwide. The company provides a line of products for transporting data, voice, and video within buildings, across campuses, and around the world. Its products are designed to transform how people connect, communicate, and collaborate. Cisco operates in five segments: United States and Canada, European markets, emerging markets, Asia Pacific, and Japan.
Cisco shares plummeted in after-hours trading on Wednesday after the company posted third-quarter earnings and fourth-quarter guidance that came in below expectations. Cisco�� revenue rose just 1.8 percent during the third quarter — the company failed to make orders it planned on producing in emerging markets like Brazil, Mexico, India, and China. Analysts had expected growth of between 3 and 5 percent. According to The Wall Street Journal, Cisco blamed the National Security Agency scandal for its lost business in China.
Top 5 Shipping Companies To Buy Right Now: Prometheus RxDx Corp (RXDX)
Prometheus RxDx Corp., incorporated in June 2009, is a wholly owned subsidiary of Prometheus Laboratories Inc. The Company is engaged in the development and commercialization of pharmaceutical and diagnostic products that enable physicians to provide individualized patient care. It focuses on the detection, diagnosis and treatment of disorders within the fields of gastroenterology and oncology. It operates in two segments: the pharmaceutical products segment that markets and sells prescription drugs, and the diagnostic testing services segment, which includes specific immunoassays to detect and differentiate diseases, pharmacogenetic testing and drug metabolite monitoring. The pharmaceutical products for gastrointestinal diseases and disorders includes ENTOCORT EC (budesonide) Capsules, which is indicated for the treatment of mild to moderate active Crohn�� disease involving the ileum and/or the ascending colon, and LOTRONEX (alosetron hydrochloride) Tablets, for use in female patients with severe diarrhea-predominant irritable bowel syndrome (IBS).
Gastroenterology Pharmaceutical Products
The pharmaceutical products for gastrointestinal diseases and disorders include Entocort EC for the treatment of mild to moderate active Crohn�� disease involving the ileum and/or ascending colon and Lotronex for treatment of a subset of women with severe diarrhea-predominant IBS. The Company sells but does not market, several other pharmaceuticals, including Imuran, Helidac Therapy, and Ridaura, in addition to a number of other diagnostic tests. It also manufactures a generic mercaptopurine product, which is sold through a third-party distributor. It only offers pharmaceutical products in the United States. It began selling Proleukin in February 2010 under an exclusive distribution and promotion agreement with Novartis. Proleukin is a recombinant human interleukin-2 for treatment in adults with metastatic renal cell carcinoma and metastatic melanoma. Proleukin therapy is a form of im! munotherapy that uses the body�� natural immune system to fight cancer. In December 2010, it signed an agreement with ThePharmaNetwork, LLC, to sell Trandate and Zyloprim.
Entocort EC is the Food and Drug Association- approved drug indicated for the induction and maintenance of clinical remission in mild to moderate active Crohn�� disease involving the ileum and/or the ascending colon. Entocort EC consists of an encapsulated formulation of budesonide granules, a glucocorticosteroid. Entocort EC is designed to release primarily in the ileum and/or the ascending colon, so that as little as 10% of the drug enters systemic circulation. Entocort EC may benefit patients by reducing glucocorticosteroid-related side effects. Lotronex is indicated for use only in women with severe diarrhea-predominant IBS who have not responded adequately to conventional therapy, whose IBS symptoms are chronic, and who have had other gastrointestinal medical conditions ruled out.
Imuran is indicated for adjunctive use in the prevention of rejection in kidney transplants and in the management of active rheumatoid arthritis. Although Imuran is not indicated for the treatment of IBD and the Company does not promote it for that indication, physicians often prescribe it for various forms of IBD, including Crohn�� disease and ulcerative colitis, as well as other autoimmune disorders. Imuran is prescribed primarily by gastroenterologists, transplant surgeons, nephrologists, rheumatologists and internal medicine specialists. Helidac Therapy (Hediac), when taken with a hydrogen (H2 ) antagonist, is indicated for the eradication of Helicobacter pylori, or H. pylori, bacteria, which causes peptic ulcers, and for patients with duodenal ulcer disease. Ridaura is approved for the treatment of active classical or definite rheumatoid arthritis in adults. Ridaura is the oral formulation of a gold salt available for the treatment of rheumatoid arthritis for patients who have not responded adequately to one or mor! e non-ste! roidal anti-inflammatory drugs. Mercaptopurine is approved for maintenance for acute lymphatic leukemia as part of a combination regimen and, although it is not indicated for the treatment of certain gastrointestinal diseases and it does not promote it for those indications, physicians often prescribe it for various forms of IBD, including Crohn�� disease and ulcerative colitis.
Trandate is approved for the management of high blood pressure, or hypertension. Trandate can be used alone or in combination with other anti-hypertensive agents, particularly thiazide and loop diuretics. Trandate is typically prescribed by cardiologists, family practitioners and internists. Trandate competes both with generics and many other drugs used to treat hypertension. In December 2010, the Company signed an agreement with ThePharmaNetwork, LLC, to sell Trandate. Zyloprim reduces serum and uric acid levels and is approved for the management of patients with gout, patients receiving certain types of chemotherapy to leukemia, lymphoma and other cancers, and patients with kidney or urinary stones. Zyloprim is prescribed by orthopedic specialists, rheumatologists, podiatrists, nephrologists and family practitioners.
Gastroenterology Diagnostic Testing Services
The diagnostic testing services are designed to aid physicians in making diagnoses with non-invasive testing and to assist them in determining therapy treatment and management, thereby helping a physician customize treatment to an individual patient. The Company performs all its diagnostic testing services in its laboratory located in San Diego, California. During the year ended December 31, 2010, it launched PROMETHEUS Crohn�� Prognostic, the serogenetic prognostic test for Crohn�� disease. The Company offers three celiac tests to physicians, including antibody tests, a genetics test and a panel that combines both the antibody and genetics tests.
The Company competes with Quest Diagnostics Incorporated and La! boratory ! Corporation of America Holdings
Advisors' Opinion:- [By James E. Brumley]
Quick - what do CytRx Corporation (NASDAQ:CYTR) and Ignyta Inc. (NASDAQ:RXDX) have in common? Yes, they're both biotech stocks, but that's not the absolute best answer right now. The most meaningful common element between RXDX and CYTR right now is, each is on the verge of a big technical breakout and deserves a spot on your watchlist. Here's a closer look at each.�
Top 10 Information Technology Stocks To Buy Right Now: Helix Energy Solutions Group Inc (HLX)
Helix Energy Solutions Group, Inc.( Helix), incorporated on November 17,1983, is an international offshore energy company that provides specialty services to the offshore energy industry, with a focus on its growing well intervention and robotics operations. The Company had had two business segments: Contracting Services and Production Facilities. Its Contracting Services seek to provide services and methodologies which it believes are critical to developing offshore reservoirs and maximizing production economi regions. Its Production Facilities segment consists of its majority ownership of a dynamically positioned floating production vessel ( Helix Producer I or HP I). In June 2013, Helix Energy Solutions Group Inc closed the previously announced sale of its pipelay vessel, the Caesar, to Trevaskis Ltd.
In January 2012, it sold its oil and gas properties within the Main Pass area of the Gulf of Mexico. On September 26, 2012, the Company sold its pipelay vessel, Intrepid, to Stabbert Maritime Holdings, LLC. On February 6, 2013, it sold Energy Resource Technology GOM, Inc. (ERT), a former wholly-owned United States subsidiary that conducted its oil and gas operations in the Gulf of Mexico.
Contracting Services Operations
The Company provides services and methodologies which it believes are critical to developing offshore reservoirs and maximizing production economics. Its life of field services are segregated into four disciplines: well intervention, robotics, subsea construction and production facilities. It provides a full range of contracting services primarily in the Gulf of Mexico, North Sea, Asia Pacific and West Africa regions primarily in deepwater.
The Company's services include production, which includes inspection, repair and maintenance of production structures, trees, jumpers, risers, pipelines and subsea equipment, well intervention, life of field support and intervention engineering; reclamation and remediation services include pluggin! g and abandonment services, pipeline abandonment services and site inspections; installation of subsea pipelines, flowlines, control umbilicals, manifold assemblies and risers, pipelay and burial, installation and tie-in of riser and manifold assembly, commissioning, testing and inspection, and cable and umbilical lay and connection. It provides oil and natural gas processing services to oil and natural gas companies, primarily those operating in the deepwater of the Gulf of Mexico using its HP I vessel. The HP I is being utilized to process production from the Phoenix.
The Company engineers, manages and conducts well construction, intervention and asset retirement operations in water depths ranging from 200 to 10,000 feet. Three of its vessels serve as work platforms for well intervention services at costs that are typically significantly less than offshore drilling rigs. In the Gulf of Mexico, its multi-service semi-submersible vessel, the Q4000, has set a series of well intervention firsts in increasingly deeper water without the use of a traditional drilling rig. In August 2012, it acquired the Discoverer 534 drillship from a subsidiary of Transocean Ltd.
The Company operates remotely operated vehicles ( ROVs), trenchers and ROVDrills designed for offshore construction and well intervention services. As global marine construction support moves to deeper water. Its chartered vessels add value by supporting deployment of its ROVs. It provides its customers with vessel availability and schedule flexibility to meet the technological challenges of their subsea activities worldwide. Its robotics assets include 49 ROVs, four trencher systems and two ROVDrills. It operate in the Gulf of Mexico, North Sea, Asia Pacific and West Africa regions. It charters four vessels to support its robotics operations and it has engaged additional vessels on short-term (spot) charters as needed. In 2012, its robotics operations had 377 vessel utilization days and 16% of global revenues derived from! alternat! ive energy contracts. Subsea construction services include the use of umbilical lay and pipelay vessels and ROVs to develop fields in the deepwater.
The Company owns interests in two production facilities in hub locations where there is potential for subsea tieback activity. It has invested in two over-sized facilities that allow the operators of these fields to tie back without burdening the operator of the hub reservoir. It owns a 50% interest in Deepwater Gateway, which owns the Marco Polo TLP located in 4,300 feet of water in the Gulf of Mexico. It also owns a 20% interest in Independence Hub which owns the Independence Hub platform, a 105-foot deep draft, semi-submersible platform located in a water depth of 8,000 feet that serves as a regional hub for up to one billion cubic feet (Bcf) of natural gas production per day from multiple ultra-deepwater fields in the eastern Gulf of Mexico.
The Company competes with Oceaneering International, Inc., Saipem S.p.A., Fugro N.V., DOF ASA, Aker Solutions ASA, Subsea 7 S.A., Technip, McDermott International, Inc., Island Offshore and Edison Chouest Offshore Companies.
Advisors' Opinion:- [By David Smith]
Helix Energy Solutions Group (NYSE: HLX )
At $2.70 billion in market capitalization, Helix is equidistant between Flotek and Superior from a size perspective. The company operates through two segments: contracting services and production facilities. - [By GuruFocus]
Helix Energy Solutions Group Inc (HLX): PRESIDENT & CEO Owen E Kratz Bought 50,000 Shares PRESIDENT & CEO of Helix Energy Solutions Group Inc (HLX) Owen E Kratz bought 50,000 shares on 10/24/2013 at an average price of $24.03. Helix Energy Solutions Group Inc has a market cap of $2.54 billion; its shares were traded at around $24.03 with and P/S ratio of 2.96.
Top 10 Information Technology Stocks To Buy Right Now: Life Technologies Corporation(LIFE)
Life Technologies Corporation operates as a global life sciences company. The company?s Molecular Biology Systems division offers molecular biology-based technologies, including basic and real-time PCR, RNA interference, DNA synthesis, sample preparation, transfection, cloning and protein expression profiling, protein analysis, and thermo-cycler instrumentation technologies. Its Cell Systems division provides cell culture media and sera, stem cells and related tools, cellular imaging products, antibodies, drug discovery services, and cell therapy related products used in the study of cell function. The company?s Genetic Systems division offers capillary electrophoresis systems and reagents, and next generation sequencing systems and reagents comprising SOLiD and Ion Torrent systems, as well as reagent kits developed specifically for applied markets, such as forensics and food safety, pharmaceutical quality monitoring, and animal health markets. Life Technologies Corporat ion also provides repair and maintenance services; and custom services, such as cell line development, custom media modification, and primers and custom assays development services. Its products offer research tools for genomics studies, proteomics studies, gene splicing, cellular analysis, and other research applications required by laboratories associated with universities, medical research centers, and government and other research institutions, as well as biotechnology, pharmaceutical, and chemical companies; and serves clinical labs, medical institutions, medical researchers, and various industries through sales and service professionals, e-commerce capabilities, and onsite supply center solutions. The company was founded in 1987 and is headquartered in Carlsbad, California.
Advisors' Opinion:- [By Rich Smith]
A rare buyout upgrade
Finally, medical equipment maker Thermo Fisher Scientific is enjoying a second straight day of gains after announcing its megabillion-dollar buyout of Life Technologies (NASDAQ: LIFE ) early Monday. An upgrade to "buy" from Mizuho Securities this morning is adding fuel to Thermo Fisher's Bunsen burner, but is this stock as hot as it's being made out to be? - [By Sean Williams]
Analyzing the short-sellers
The overwhelming boost in the number of short-sellers stems from Thermo Fisher Scientific pricing the largest public stock offering all year earlier this month. The $2.2 billion offering comes on the heels of its agreement to purchase rival Life Technologies (NASDAQ: LIFE ) for $13.6 billion. As with Pfizer, there are a lot of mixed emotions about the deal and the share offering. - [By Rich Smith]
No sooner had Life Technologies Corp. (NASDAQ: LIFE ) announced its successful purchase of KDR Biotech last week, then out came Thermo Fisher Scientific (NYSE: TMO ) with a $13.6 billion bid to buy Life Technologies itself.
- [By David Williamson]
Shares of Life Technologies (NASDAQ: LIFE ) jumped in January, when the company announced it was looking for a potential buyer, and it may now be close to a decision, with solid offers having come in both from Blackstone Group (NYSE: BX ) and Thermo Fisher Scientific (NYSE: TMO ) . What will this biotech decide, and how will it affect investors? In this video, Motley Fool health-care analyst David Williamson gives us a breakdown of the offers on the table, and how investors could be affected depending on the outcome.
Top 10 Information Technology Stocks To Buy Right Now: Immersion Corporation(IMMR)
Immersion Corporation develops, manufactures, licenses, and supports a range of hardware and software technologies and products that enhance digital devices with touch interaction. The company provides haptic technologies that allow people to use their sense of touch when operating a variety of digital devices. It licenses its technologies to the manufacturers of automotive, consumer electronics, gaming, commercial and industrial controls, medical, and mobile communications products under the TouchSense brand. The company?s product portfolio includes TouchSense 1000, TouchSense 2000, TouchSense 3000, TouchSense 4000, TouchSense 5000, and TouchSense 6000. It also offers turn-key engineering and integration services, design kits for prototyping, authoring tools, and application programming interfaces, as well as platform independent solutions. The company operates primarily in North America, Europe, and the Far East. Immersion Corporation was founded in 1993 and is headquar tered in San Jose, California.
Advisors' Opinion:- [By Seth Jayson]
Margins matter. The more Immersion (Nasdaq: IMMR ) keeps of each buck it earns in revenue, the more money it has to invest in growth, fund new strategic plans, or (gasp!) distribute to shareholders. Healthy margins often separate pretenders from the best stocks in the market. That's why we check up on margins at least once a quarter in this series. I'm looking for the absolute numbers, so I can compare them to current and potential competitors, and any trend that may tell me how strong Immersion's competitive position could be.
Top 10 Information Technology Stocks To Buy Right Now: Gazprom OAO (GAZP)
Gazprom OAO is a Russia-based company engaged in the operation of gas pipeline systems and gas supply to European countries. In addition, it is involved in the oil production and refining activities, as well as energy generation. It�� activities comprise exploration and production of gas, transportation of gas, sale of gas domestically and abroad, gas storage, production of crude oil and gas condensate, processing of oil, gas condensate and other hydrocarbons, and sales of refined products, as well as electric and heat energy generation and sales. On January 9, 2013, the Company sold its 76.69% stake in Zapsibgazprom OAO and whole stake in March Kauno termofikacijos elektrine. In April 2013, it also created Gazprom Invest LLC, as well as, signed a purchase-sale contract for shares in 72 gas distribution organizations belonging to Rosneftegaz OAO. In November 2013, the Company raised its stake to 100% in CJSC Gazprom Neft Orenburg. Advisors' Opinion:- [By Ian Sayson]
Russian stocks fell for a third day as crude oil, the nation�� chief export earner, retreated. Mechel fell to the lowest level since Sept. 6, while OAO Gazprom (GAZP), the natural-gas export monopoly, retreated 0.9 percent.
Top 10 Information Technology Stocks To Buy Right Now: Goodrich Petroleum Corporation (GDP)
Goodrich Petroleum Corporation, an independent oil and natural gas company, engages in the exploration, development, and production of oil and natural gas. The company holds interest in the Eagle Ford Shale Trend located in South Texas; the Haynesville Shale and Cotton Valley Taylor Sand in northwest Louisiana and East Texas; and the Tuscaloosa Marine Shale located in southwest Mississippi and southeast Louisiana. It owns working interests in 392 producing oil and natural gas wells located in 32 fields in 8 states. As of December 31, 2012, the company had estimated proved reserves of approximately 254.0 billion cubic feet of natural gas, 5.1 million barrels of crude oil or other liquid hydrocarbons (MMBbls) of natural gas liquids, and 8.1 MMBbls of oil and condensate. Goodrich Petroleum Corporation was founded in 1995 and is based in Houston, Texas.
Advisors' Opinion:- [By Roberto Pedone]
One under-$10 independent oil and gas player that's starting to trend within range of triggering a big breakout trade is Goodrich Petroleum (GDP) which is engaged in the exploration, development, and production of oil and natural gas. This stock has been smashed lower by the bears over the last six months, with shares down sharply by 64%.
If you take a glance at the chart for Goodrich Petroleum you'll see that this stock has been downtrending badly for the last two months and change, with shares falling sharply lower from its high of $22.61 to its new 52-week low of $7.01 a share. During that downtrend, shares of GDP have been making mostly lower highs and lower lows, which is bearish technical price action. That said, shares of GDP have now started to bounce higher off its 52-week low and it's beginning to trend within range of triggering a big breakout trade above some key near-term overhead resistance levels.
Traders should now look for long-biased trades in GDP if it manages to break out above some near-term overhead resistance levels at $9.48 to around $9.50 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average volume of 2.07 million shares. If that breakout develops soon, then GDP will set up to re-test or possibly take out its next major overhead resistance levels at its 50-day moving average of $11.80 to $12.09 a share., or even $13 to $14 a share.
Traders can look to buy GDP off weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support levels at $8.30 to $8 a share. One can also buy GDP off strength once it starts to clear those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
Must Read: 10 Stocks Carl Icahn Loves in 2014
- [By Vera Yuan]
Five years of central bank action have contributed to a world of high valuations across asset classes. In the equity world, bears point to the elevated CAPE ratio (cyclically adjusted price-to- earnings (P/E), calculated on the last 10 years inflation-adjusted earnings, also known as the Shiller P/E) and the related high level of corporate profitability. The current levels of the CAPE ratio in the U.S. (currently at 26 times, versus the long-run average of 16 times3) have historically been associated with low medium to long term returns, while corporate profits��share of gross domestic product (GDP) has mean reverted in the past. Bulls suggest that corporate profits can remain strong, as labor�� bargaining power and government�� taxing power are both structurally impaired, and that valuations look reasonable, if you just compare them to the post-1990, post-Cold War world.
Top 10 Information Technology Stocks To Buy Right Now: Lloyds Banking Group PLC (LYG)
Lloyds Banking Group plc, incorporated on October 21, 1985, is a holding company. The Company is a financial services group providing a range of banking and financial services, primarily in the United Kingdom, to personal and corporate customers. The Company operates in four segments: Retail, Commercial Banking, Wealth, Asset Finance and International and Insurance. Retail provides banking, mortgages and other financial services to personal customers in the United Kingdom. Commercial Banking provides banking and related services to business clients, from small businesses to large corporate. Wealth, Asset Finance and International provides private banking and asset management and asset finance in the United Kingdom and overseas and operates the Company�� international retail businesses. Insurance provides long term savings, protection and investment products in the United Kingdom and Europe and provides general insurance to personal customers in the United Kingdom.
Retail
The Retail division operates the retail bank in the United Kingdom and is a provider of current accounts, savings, personal loans, credit cards and mortgages. This includes a range of current accounts including packaged accounts and basic banking accounts. It is also the provider of personal loans in the United Kingdom, as well as being the United Kingdom�� credit card issuer. Retail is the private sector savings provider in the United Kingdom. It is also a general insurance and bancassurance distributor, offering a range of long-term savings, investment and general insurance products.
Commercial Banking
The Commercial Banking division supports the Company�� business clients from small businesses to corporate. Commercial Banking provides support to corporate clients through the provision of core banking products, such as lending, deposits and transaction banking services whilst also offering clients expertise in capital markets (private placements, bonds and syndicated loans), ! financial markets (foreign exchange, interest rate management, money market and credit) and private equity.
Wealth, Asset Finance and International
Wealth, Asset Finance and International consists of the Company�� the United Kingdom and international wealth businesses, the Company�� the United Kingdom and international asset finance and online deposit businesses along with its international retail businesses. The Wealth business consists of private banking and asset management. Wealth�� private banking operations cater to the range of wealth clients from affluent to Ultra High Net Worth within the United Kingdom, Channel Islands and Isle of Man, and internationally. Asset Finance consists of a number of leasing and speciality lending businesses in the United Kingdom, including Lex Autolease and Black Horse Motor and Personal Finance along with its leasing and specialty lending businesses in Australia and its European online deposit business. The international business comprises its non-core banking business outside the United Kingdom, with the exception of corporate business written through the Commercial Banking division. This primarily consists of Ireland, Retail Europe and Asia.
Insurance
The Insurance division provides long-term savings, protection and investment products and general insurance products to customers in the United Kingdom and Europe. The United Kingdom Life, Pensions and Investments business provides long-term savings, protection and investment products distributed through the bancassurance, intermediary and direct channels of the Lloyds TSB, Halifax, Bank of Scotland and Scottish Widows brands. The European Life, Pensions and Investments business distributes products primarily in the German market under the Heidelberger Leben and Clerical Medical brands. The General Insurance business is a distributor of home insurance in the United Kingdom, with products sold through the branch network, direct channels and strategic corporate! partners! . It operates primarily under the Lloyds TSB, Halifax and Bank of Scotland brands.
Advisors' Opinion:- [By Andrew Marder]
When the financial world fell apart a few years ago -- you remember -- British banks got mauled. Barclays, Lloyds Banking Group (NYSE: LYG ) , Royal Bank of Scotland (NYSE: RBS ) , and a handful more that have since been absorbed or disbanded -- no one made it out unscathed. The problems came to a head when U.K. taxpayers were forced to bail out Lloyds and RBS. That bailout cost the U.K. an reported 23 billion pounds through the end of 2012.�
No comments:
Post a Comment